COVID-19 Therapeutics Accelerator

This page shows the latest COVID-19 Therapeutics Accelerator news and features for those working in and with pharma, biotech and healthcare.

Novartis reveals plans for a zero-profit COVID-19 drugs portfolio

Novartis is also involved in the COVID-19 Therapeutics Accelerator, coordinated by the Bill &Melinda Gates Foundation, Wellcome and Mastercard, which is committed to ensuing that any treatment for COVID-19 ... The COVID-19 pandemic, like every health

Latest news

Novartis forms coronavirus alliance with life sciences companies

The data will be shared with the COVID-19 therapeutics accelerator created by the Bill &Melinda Gates Foundation, Wellcome and Mastercard. ... Last week, Novartis launched a $20m response fund to support communities around the world that have been most
Novartis launches $20m COVID-19 response fund

In addition to the response fund, Novartis has also entered into collaborative research efforts including the COVID-19 therapeutics accelerator, which was recently launched by the Bill &Melinda Gates Foundation, Wellcome ... It has also collaborated on a
Gates Foundation, Wellcome launch fast-track COVID-19 therapy fund

The COVID-19 Therapeutics Accelerator will focus on identifying, assessing, developing and scaling-up potential treatments for the virus, which has now taken a foothold in an increasing number of countries ... The aim is to share research, coordinate

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

Exploiting the value of data in pharma

The value of data collaboration. In March this year, the Bill &Melinda Gates Foundation launched an initiative called the COVID-19 Therapeutics Accelerator philanthropically bringing together a consortium of 15 of ... For example, Novartis (the company
Working together against COVID-19

Therefore words like ‘war’, ‘fight’ and ‘battle’ are being seen within the COVID-19 online conversations. ... A number of top pharma companies are included in the newly formed partnership, the COVID-19 Therapeutics Accelerator, including Eli